Deuterated Polyunsaturated Fatty Acids Alleviate In Vitro Skeletal Muscle Dysfunction Induced by Oxidative Stress
Xinyue Lu1,2,3, Olga L Sharko4, Vadim V Shmanai4
1Department of Animal Sciences, College of Agriculture, Purdue University, West Lafayette, IN, USA.
Biorxiv : the Preprint Server for Biology
|January 9, 2026
Summary
Deuterated polyunsaturated fatty acids (D-PUFAs) protect muscle cells from oxidative stress and lipid peroxidation. This study suggests D-PUFAs may be a novel therapeutic strategy against muscle wasting diseases.
Area of Science:
- Biochemistry
- Cell Biology
- Muscle Physiology
Background:
- Oxidative stress causes lipid peroxidation, contributing to skeletal muscle atrophy in diseases.
- Polyunsaturated fatty acids (PUFAs) are vital for muscle cell membranes but prone to peroxidation.
- Current therapies for muscle wasting due to lipid peroxidation are limited.
Purpose of the Study:
- To investigate if deuterated PUFAs (D-PUFAs) can protect muscle cells from oxidative stress.
- To evaluate the potential of D-PUFAs in preventing muscle cell dysfunction and atrophy.
Main Methods:
- Cultured myotubes were treated with native (H-) and deuterated (D-) forms of long-chain PUFAs (arachidonic acid, eicosapentaenoic acid, docosapentaenoic acid, docosahexaenoic acid).
- Cells were exposed to reactive oxygen species (ROS) or the ferroptosis inducer erastin.
- Lipid peroxidation levels, myotube growth, and expression of antioxidant enzymes were assessed.
Main Results:
- D-PUFAs, unlike H-PUFAs, protected myotubes against ROS-induced lipid peroxidation and dysfunction.
- D-PUFAs also protected against erastin-induced ferroptosis and preserved myogenic differentiation.
- D-PUFAs modulated the expression of endogenous antioxidant enzymes and muscle-specific protein ligases.
Conclusions:
- Deuteration of PUFAs limits their susceptibility to lipid peroxidation.
- D-PUFAs show promise as a novel therapeutic approach to combat oxidative stress-induced skeletal muscle atrophy.
- This strategy could offer new treatments for various musculoskeletal diseases characterized by muscle wasting.
More Related Videos
Related Concept Videos
Skeletal Muscle Relaxants: Adverse Effects
1.2K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
1.2K
Muscle Recovery and Fatigue
4.5K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
4.5K


